Operating Income: The income after operating expenses.
Coya Therapeutics, Inc. (COYA) had Operating Income of $-2.43M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$3.56M |
|
$-2.12M |
|
-- |
|
$3.56M |
|
$6.00M |
|
|
Operating Income |
$-2.43M |
$0.32M |
|
$-2.12M |
|
$-2.12M |
|
$-2.12M |
|
$-2.12M |
|
$-2.12M |
|
$-2.12M |
|
$-2.43M |
|
$-2.43M |
|
16.73M |
|
16.73M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$32.02M |
|
$0.02M |
|
$0.02M |
|
$32.04M |
|
$3.67M |
|
-- |
|
$1.09M |
|
$4.76M |
|
$27.28M |
|
$27.28M |
|
$27.28M |
|
16.74M |
|
| Cash Flow Statement Financials | |
$-9.73M |
|
$-0.52M |
|
$0.04M |
|
$38.34M |
|
$28.13M |
|
$-10.21M |
|
$3.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-68.26% |
|
-68.26% |
|
-- |
|
-59.36% |
|
-59.36% |
|
$-10.25M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
-- |
|
-- |
|
-- |
|
-7.75% |
|
-7.75% |
|
-6.60% |
|
-7.75% |
|
$1.63 |
|
$-0.61 |
|
$-0.58 |
|